Developed with input from federal regulators, AABB’s regulatory resources are clear, user-friendly tools that help blood centers and transfusion services protect donor and patient safety at each step in the transfusion chain.
Reporting Fatalities Related to Blood Transfusion and Donation to FDA
REGULATORY UPDATE: CBER Adds Donation Suitability Draft Guidance to 2021 Agenda
April 14, 2021
CDC, FDA Recommend Pausing Distribution of Johnson & Johnson COVID-19 Vaccine
April 13, 2021
REGULATORY UPDATE: FDA Releases 2020 Biological Product Deviation Report Summary
©2020 AABB. All Rights Reserved.4550 Montgomery Avenue, Suite 700, North Tower, Bethesda, MD 20814 Phone: 301.907.6977 | Fax: 301.907.6895 Web Design and Development by Matrix Group International, Inc.